Your Search Results

Interventions for heart failure: shock and beyond

20 May 2026 – From EuroPCR 2026

Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.

Best cases in stable CAD

20 May 2026 – From EuroPCR 2026

This session showcases exemplary cases in stable coronary artery disease, emphasizing complex diagnostic and therapeutic challenges such as ambiguous angiographic findings, refractory vasospastic angina, catastrophic no-reflow phenomena, and the application of physiology-guided PCI and coronary sinus reducers.

New frontiers - The evolving role of nurses and allied professionals

20 May 2026 – From EuroPCR 2026

This session explores the evolving role of nurses and allied professionals in interventional cardiology, addressing challenges in role definitions, collaborative responsibilities with physicians, and strategies for professional recognition and safety enhancement within the cath lab environment.

Redo TAVI challenges

20 May 2026 – From EuroPCR 2026

Focused on the complexities of redo transcatheter aortic valve implantation (TAVI), this session covers innovative techniques such as jailed-balloon to prevent sinus sequestration, CT-guided emergency valve-in-valve procedures, alternative access routes, and strategies to manage coronary occlusion risks during multiple valve interventions.

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.